Literature DB >> 21170279

Pancreatic complications following orthotopic liver transplantation.

Katsuhiko Yanaga1, Mitsuo Shimada, Robert D Gordon, Andreas G Tzakis, Leonard Makowka, J Wallis Marsh, Andrei C Stieber, Satoru Todo, Shunzaburo Iwatsuki, Thomas E Starzl.   

Abstract

During fiscal year 1986, 40 out of 196 patients (21%) developed hyperamylasemia following orthotopic liver transplantation. The placement of a retropancreatic aortohepatic arterial interposition graft was associated with hyperamylasemia (p < 0.025). Eight patients (20%) developed clinically significant acute pancreatitis and its sequelae; abscesses and pseudocysts each in 2. Pancreatitis was attributable to the retropancreatic arterial graft in 4, viral infection in 2 and obstruction of the pancreatic duct in 1 patient. All 4 patients with arterial graft-related pancreatitis exhibited poor graft function immediately postoperatively, of whom 2 required retransplantation - both of which failed to function. Five patients died (63%); 2 from primary graft non-function, 2 due to sepsis and 1 from systemic cytomegalovirus infection. We conclude that acute pancreatitis after liver transplantation is a life-threatening complication which is often associated with graft non-function.

Entities:  

Year:  1992        PMID: 21170279      PMCID: PMC3002138     

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  19 in total

1.  Hypercalcemia associated with pancreatitis and hyperamylasemia in renal transplant recipients. Data from the Minnesota randomized trial of cyclosporine versus antilymphoblast azathioprine.

Authors:  T W Frick; D S Fryd; D E Sutherland; R L Goodale; R L Simmons; J S Najarian
Journal:  Am J Surg       Date:  1987-11       Impact factor: 2.565

2.  Hyperamylasemia after cardiac surgery. Incidence, significance, and management.

Authors:  D W Rattner; Z Y Gu; G J Vlahakes; A L Warshaw
Journal:  Ann Surg       Date:  1989-03       Impact factor: 12.969

3.  Acute pancreatitis and hyperamylasemia in renal homograft recipients.

Authors:  I Penn; A L Durst; M Machado; C G Halgrimson; A S Booth; C W Putman; C G Groth; T E Starzl
Journal:  Arch Surg       Date:  1972-08

4.  Portal vein grafts in hepatic transplantation.

Authors:  B W Shaw; S Iwatsuki; K Bron; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1985-07

5.  Alternative methods of arterialization of the hepatic graft.

Authors:  B W Shaw; S Iwatsuki; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1984-11

6.  The nature and significance of hyperamylasemia follwing operation.

Authors:  R Morrissey; J E Berk; L Fridhandler; D Pelot
Journal:  Ann Surg       Date:  1974-07       Impact factor: 12.969

7.  Problematic vascular reconstruction in liver transplantation. Part I. Arterial.

Authors:  R M Goldstein; C L Secrest; G B Klintmalm; B S Husberg
Journal:  Surgery       Date:  1990-05       Impact factor: 3.982

8.  Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era.

Authors:  A G Tzakis; R D Gordon; B W Shaw; S Iwatsuki; T E Starzl
Journal:  Transplantation       Date:  1985-12       Impact factor: 4.939

9.  Hepatobiliary and pancreatic complications of cyclosporine therapy in 466 renal transplant recipients.

Authors:  M I Lorber; C T Van Buren; S M Flechner; C Williams; B D Kahan
Journal:  Transplantation       Date:  1987-01       Impact factor: 4.939

10.  The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs.

Authors:  T E Starzl; K A Porter; N Kashiwagi; I Y Lee; W J Russsell; C W Putnam
Journal:  Surg Gynecol Obstet       Date:  1975-04
View more
  1 in total

1.  Acute pancreatitis following oesophagogastroduodenoscopy.

Authors:  Nnamdi Arinze Nwafo
Journal:  BMJ Case Rep       Date:  2017-12-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.